Nurix therapeutics announces regulatory clearance to initiate phase 1 clinical trial of nx-5948 and presents new preclinical data at the american society of hematology annual meeting

U.k. regulatory authorities grant clinical trial authorization with dosing of first patient anticipated in the first half of 2022

NRIX Ratings Summary

NRIX Quant Ranking